Institutional Portfolio Reshaping
Bard Associates Increases Portfolio Stakes Across Five Different Companies in Second Quarter
Key Points
BlackRock Inc. opened a new position in Crexendo in the second quarter, with holdings valued at about $7.96 million.
Caitong International Asset Management Co. Ltd substantially expanded its Pennant Group stake, increasing by 154.2% in the fourth quarter to 1,182 shares worth about $33,000 after acquiring an additional 717 shares.
Paysign CFO Jeffery Bradford Baker sold 35,000 shares on August 12 at an average price of $12.62, reducing his direct stake to 542,171 shares valued at about $6.84 million; the sale represents a 6.06% decrease in the position.
Vanguard Group boosted its stake in NeuroOne Medical Technologies by 31.2% in the third quarter, now owning 1,578,237 shares valued at about $1.403 million.
Comerica Bank and Parkside Financial Bank & Trust increased their holdings in Tortoise Energy Infrastructure; Comerica Bank up 27.8% to 1,111 shares worth $45,000, while Parkside Financial Bank & Trust owns 1,000 shares worth about $41,000.
Bard Associates Inc., a major institutional investor, disclosed significant new stakes across five companies in Q2, with its largest position in Tortoise Energy Infrastructure worth approximately $8.4 million. The firm also invested heavily in Crexendo ($2.69 million), NeuroOne Medical Technologies ($929,000), Paysign ($406,000), and The Pennant Group ($924,000). Defense World reported that the moves reflect Bard's diversified strategy across mid-cap and energy infrastructure stocks, with coordinated activity from other major players including Vanguard Group, BlackRock, and Arrowstreet Capital.
Tortoise Energy Infrastructure Emerges as Largest Bet
Tortoise Energy Infrastructure became Bard's biggest Q2 investment at 196,455 shares valued near $8.4 million. Banks also increased positions. Comerica Bank raised its stake by 27.8% to 1,111 shares worth $45,000. Parkside Financial Bank & Trust owns 1,000 shares valued around $41,000. The coordinated buying signals institutional confidence in the energy infrastructure sector.
BlackRock and Vanguard Reshape Healthcare Positions
BlackRock opened a new position in Crexendo during Q2, acquiring shares worth $7.96 million. Separately, Vanguard Group boosted its NeuroOne Medical Technologies stake by 31.2% in Q3. Vanguard now holds 1,578,237 shares valued at approximately $1.4 million. Defense World noted these moves demonstrate institutional appetite for smaller healthcare and tech plays.
Paysign CFO Reduces Holdings While Firm Raises Capital
Paysign's CFO Jeffery Bradford Baker sold 35,000 shares on August 12 at $12.62 each. The sale cut his direct stake by 6.06% to 542,171 shares worth $6.84 million. The insider move came as Bard Associates acquired 49,576 Paysign shares worth roughly $406,000, showing mixed signals about the payment company's near-term prospects.
Caitong Dramatically Expands Pennant Group Exposure
Caitong International Asset Management Co. Ltd surged its Pennant Group position by 154.2%, purchasing an additional 717 shares in Q4. The fund now owns 1,182 shares worth approximately $33,000. Bard Associates separately acquired 25,000 Pennant shares valued near $924,000. The twin moves from both firms suggest growing confidence in the healthcare services provider.
Sentiment
Mostly PositivePublishers
16
Articles
13
Reach
29
